Expert advice: Stocks that can make you money

161003 Investors following SBI. Share this News with them.

0

Like this story, share it with millions of investors on M3

Expert advice: Stocks that can make you money

In a chat with CNBC-TV18's Sonia Shenoy and Ekta Batra, SP Tulsian gives fundamental view and Vijay Bhambwani of bsplindia.com gives technical view on various stocks/sectors.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Your Stocks on CNBC-TV18 Watch the full show » RELATED NEWS Mkt may hit 5400-5500 in worst case: Dalton Cap Anand Tandon optimistic on near-term mkt pullback Banks a good buy post correction: Kotak AMC ALSO READ See what other experts are saying about markets See what FIIs are saying about the markets See what Udayan Mukherjee is saying about the markets

In a chat with CNBC-TV18's Sonia Shenoy and Ekta Batra, SP Tulsian gives fundamental view and Vijay Bhambwani of bsplindia.com gives technical view on various stocks/sectors.

Here are the expert views on various stocks/sector:

On State Bank of India (SBI):

Tulsian says, "The recent correction in the market has really made the public sector bank stocks quite attractive. In fact somebody who wants to play very safe that he doesn't mind even waiting for couple of months also, but he wants to catch it at bottom, probably Rs 2,800 looks the level where he should look to buy. But my advice for him would be that probably to wait for a fall of Rs 70. He may lose an opportunity of stock going up by maybe Rs 100-150 because we keep the good bounce back coming up in the stock, the moment sentiments keeps improving. So, in my view, SBI is virtually ruling at its bottom and buying is a advice at current levels."

On Ranbaxy :

Tulsian says, "I have been maintaining quite positive view on the stock for last four-six months. I see the normalcy returning back for the company on the USFDA front because they had a lot of problems, lot of litigations and all that. But now with the new management probably Lipitor could be the real big booster, which is likely to happen or the launch is likely to happen from November 2011. So, maybe one year horizon is may be little short. If somebody can keep a view of two-three years, in my view in three-year time, one can expect the stock to again breach four digit mark. But still somebody wants to have a one year's view, I don't think that Rs 700 to Rs 720 should be the target one can look for on the stock because I don't think that this will just give a linear kind of growth. The moment we will be seeing good improvement in the financial performance that can give a very good upside on the stock from here on. So, I have quite positive view, buying is advised at the current levels."

Bhambwani says, "This is a long-term story that's likely to yield good results, probably even market outperformer as relative to the Nifty 50. Since its trading at Rs 570, the short-term inflection point or resistance would be close to Rs 580-585. Once it trades consistently above Rs 580 or Rs 585 band, I think going past the immediate hurdle of Rs 625 and scaling the all time peak of Rs 650 will not really be to much of a problem. On the downsides, ample support exists close to the Rs 520 odd levels. Looking at the volatility the market is undergoing, there might be a possibility that stocks including Ranbaxy may just be available at lower levels, so one gets a chance to basically average out one's cost.